BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31857554)

  • 1. A Severe Form of M - protein Negative Distal Acquired Demyelinating Symmetric Neuropathy.
    Ong TL; Goh KJ; Shahrizaila N; Wong KT; Tan CY
    Neurol India; 2019; 67(6):1532-1535. PubMed ID: 31857554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cyclophosphamide.
    Leitch MM; Sherman WH; Brannagan TH
    Muscle Nerve; 2013 Feb; 47(2):292-6. PubMed ID: 23168526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy-responsive allodynia due to distal acquired demyelinating symmetric (DADS) neuropathy.
    Liewluck T; Engelstad JK; Mauermann ML
    Muscle Nerve; 2016 Nov; 54(5):973-977. PubMed ID: 27251375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
    Larue S; Bombelli F; Viala K; Neil J; Maisonobe T; Bouche P; Musset L; Fournier E; Léger JM
    Eur J Neurol; 2011 Jun; 18(6):899-905. PubMed ID: 21199182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Inflammatory Demyelinating Polyneuropathy Manifesting as Neuropathy With Liability to Pressure Palsies: A Case Report.
    Shah A; Rison RA; Beydoun SR
    J Clin Neuromuscul Dis; 2015 Dec; 17(2):78-83. PubMed ID: 26583495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness.
    Mygland A; Monstad P
    Arch Neurol; 2003 Feb; 60(2):260-4. PubMed ID: 12580713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients who meet electrodiagnostic criteria for CIDP rarely present with a sensory predominant DSP phenotype.
    Davalos L; London ZN; Stino AM; Gallagher GW; Callaghan BC; Wieland CM; Nowacek DG
    Muscle Nerve; 2021 Jun; 63(6):881-884. PubMed ID: 33745140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular ultrasound findings in distal acquired demyelinating symmetric variant of chronic inflammatory demyelinating polyneuropathy.
    Vu QD; Cartwright MS
    Muscle Nerve; 2017 Nov; 56(5):E44-E45. PubMed ID: 28667663
    [No Abstract]   [Full Text] [Related]  

  • 9. Utility of somatosensory evoked potentials in chronic acquired demyelinating neuropathy.
    Yiannikas C; Vucic S
    Muscle Nerve; 2008 Nov; 38(5):1447-1454. PubMed ID: 18932207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distal acquired demyelinating symmetric neuropathy.
    Katz JS; Saperstein DS; Gronseth G; Amato AA; Barohn RJ
    Neurology; 2000 Feb; 54(3):615-20. PubMed ID: 10680792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polyneuropathy involving cranial nerves associated with monoclonal IgM antibodies with anti-MAG/SGPG/SGPLG/sulfatides activity].
    Drouet A; Caudie C; Vallat JM; Ruel JH; Felten D; Guilloton L; Giraud P
    Rev Neurol (Paris); 2006 Jun; 162(6-7):760-6. PubMed ID: 16840988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of chronic inflammatory demyelinating polyneuropathy.
    Rotta FT; Sussman AT; Bradley WG; Ram Ayyar D; Sharma KR; Shebert RT
    J Neurol Sci; 2000 Feb; 173(2):129-39. PubMed ID: 10675657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
    Nobile-Orazio E
    J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cranial nerve involvement in typical and atypical chronic inflammatory demyelinating polyneuropathies.
    Shibuya K; Tsuneyama A; Misawa S; Suichi T; Suzuki Y; Kojima Y; Nakamura K; Kano H; Prado M; Kuwabara S
    Eur J Neurol; 2020 Dec; 27(12):2658-2661. PubMed ID: 32876980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythromelalgia-like presentation of chronic acquired demyelinating polyneuropathy in a setting of past alcohol abuse.
    Chuquilin M; Dhand UK
    Neuromuscul Disord; 2016 Feb; 26(2):176-80. PubMed ID: 26804376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distal acquired demyelinating symmetric neuropathy associated with anti-GM1 antibodies: is this a CIDP variant?
    Remiche G; Kentos A; Mavroudakis N
    Acta Neurol Belg; 2010 Mar; 110(1):103-6. PubMed ID: 20514936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent topics of chronic inflammatory demyelinating polyneuropathy].
    Iijima M
    Rinsho Shinkeigaku; 2012; 52(11):917-9. PubMed ID: 23196467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical spectrum of chronic acquired demyelinating polyneuropathies.
    Saperstein DS; Katz JS; Amato AA; Barohn RJ
    Muscle Nerve; 2001 Mar; 24(3):311-24. PubMed ID: 11353415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy.
    Ikeda S; Koike H; Nishi R; Kawagashira Y; Iijima M; Katsuno M; Sobue G
    J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):988-996. PubMed ID: 31227562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathy associated with immunoglobulin M monoclonal gammopathy: A combined sonographic and nerve conduction study.
    Goedee HS; Notermans NC; Visser LH; van Asseldonk JH; Franssen H; Vrancken AFJE; Nikolakopoulos S; van den Berg LH; van der Pol WL
    Muscle Nerve; 2019 Sep; 60(3):263-270. PubMed ID: 31269243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.